The impact of high-dose melphalan on myeloma-related mutations & risk level
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2022-06-14
Просмотров: 1323
Описание: Nathan Sweeney, PhD, HealthTree, Lehi, UT, briefly discusses a study which investigated whether receiving high-dose melphalan would increase mutation burden and risk level in myeloma patients. Dr Sweeney discusses some results from this study and the impact of both high-dose melphalan and standard chemotherapy on disease burden. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: